NR ACLS
AU Chamberland,M.E.; Khabbaz,R.F.
TI Emerging issues in blood safety
QU Infectious Disease Clinics of North America 1998 Mar; 12(1): 217-29
PT journal article; review; review, academic
AB Improvements in donor selection, testing of donors for markers of infection, and viral inactivation of plasma-derived products have helped reduce the risk of transfusion-associated infections, including hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency viruses (HIV). The potential for transmission of emerging infections is illustrated by current concerns about group O strains of HIV, nonenveloped viruses, newly discovered microbial agents, prions, Chagas' disease, tick-borne infections, and the need to assess the frequency of transfusion reactions associated with bacterial contamination.
ZR 84
MH Bacterial Infections/diagnosis/epidemiology/*transmission; Blood Donors; *Blood-Borne Pathogens; Disease Transmission, Horizontal; Human; Prion Diseases/diagnosis/epidemiology/*transmission; Protozoan Infections/diagnosis/epidemiology/*transmission; Virus Diseases/diagnosis/epidemiology/*transmission
AD Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
SP englisch
PO USA